Physician profile
Ryan Walker
NPI 1184258279
$3,265.47
in general payments reported to CMS, 2019-2025
16 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $440 · 2023: $1,106 · 2024: $1,381 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,825.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $887.02 | 2022-2025 | |
| Supernus Pharmaceuticals, INC. | $704.73 | 2023-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $262.67 | 2023-2024 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $227.56 | 2023-2025 | Abilify Mycite, Rexulti |
| Janssen Pharmaceuticals, INC | $193.63 | 2022-2025 | Spravato |
| Corium, LLC | $170.93 | 2022-2025 | Azstarys |
| Lundbeck LLC | $166.01 | 2024-2025 | Rexulti |
| Axsome Therapeutics, INC. | $145.71 | 2024-2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $117.77 | 2023-2024 | Quviviq |
| Tris Pharma INC | $108.50 | 2023-2025 | Dyanavel Xr |
| Alkermes, INC. | $89.33 | 2022 | |
| Almatica Pharma LLC | $82.75 | 2024 | Loreev Xr |
| Ironshore Pharmaceuticals INC. | $37.02 | 2023 | Jornay Pm |
| Vanda Pharmaceuticals INC. | $31.61 | 2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $25.95 | 2025 | Cobenfy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $14.28 | 2024 | Xelstrym, Secuado |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.